In general, the mutation detection rates for BRCA1 and BRCA2 genes in the members of Slovenian families with breast and/or ovarian cancer are comparable with the mutation frequencies in these two genes reported for other countries [15,17,25]. This evidence concerns the gene BRCA1 and ovarian carcinoma.